Pioneers in cancer care

The Aktis Oncology team is pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumors.

Aktis Board of Directors

Jim Carmichael, MD

Alex Tkachenko, PhD

Kevin Raidy

Jason Ruth

Markus Reschke, PhD

Brian Goodman, PhD


Our investor syndicate includes other undisclosed investors.

Join us

Join a team dedicated to discovering and developing transformative therapies that put solid cancers into remission.

View Careers
Scientist in lab coat working at computer desk